EUVIMED · CrossrefJournal
Influenza and Other Respiratory Viruses
ISSN 1750-2640 · Wiley
Latest articles
A Mechanistic Viral Host Perturbation Score (VHPS) Reveals Shared and Virus‐Specific Transcriptional Programs Across Human Respiratory Infections
RSV Disease Among Hospitalized Children: Second vs. First Year of Life Multicenter Study
Validating Time‐Series Regression Model Predictions of Influenza Mortality: An Interrupted Time‐Series Analysis
Temporal Shifting of Influenza Subtype Dynamics in Pakistan Following the COVID‐19 Pandemic: A 10‐Year FluNet Analysis, 2015–2024
Development and Validation of Serological Tests for Avian Influenza Antibodies in Meat Juice From Wild Birds
Host‐Age Structure in Influenza A(H3N2) HA Lineage Transitions in South Korea, 2009–2025
Clinical Spectrum, Outcomes, and Factors Associated With Encephalopathy in Children With Influenza‐Associated Neurological Complications: A Retrospective Cohort Study
A Canadian Laboratory‐Based Retrospective of the 2024/2025 Influenza Season: Monitoring the Impacts of Influenza Evolution on Viral Antigenicity and Antiviral Susceptibility
Near‐Universal Protection Against Respiratory Syncytial Virus Through a Hybrid Strategy: Lessons From Bogotá
Reduction in Emergency Department Attendances for Acute Bronchiolitis in Infants Aged Under 1 Year in England During Winter 2025/2026 Following Introduction of Maternal RSV Vaccination
Impact of Non‐Pharmaceutical Interventions Targeted at COVID‐19 Pandemic on Influenza Burden—A Systematic Review and Meta‐Analysis
Issue Information
Evaluating Analytic Approaches to Determining Respiratory Syncytial Virus Seasonality—United States, 2014–2024
Navigating the Future of Respiratory Infections: Key Insights From International Congress in Singapore, 17–20 September 2025
Immunogenicity of a Multi‐Epitope Influenza Composite Peptide Vaccine Targeting Human, Swine, and Avian Viruses: Advancing Pandemic Preparedness
Hypertransaminasemia Is a Marker of Severity in Children Hospitalized for Influenza
Antigenic Variation and Immune Recognition Inference From the COVID‐19 Pandemic: An In Silico Comparative Analysis of Spike T Cell Epitopes From the SARS‐CoV‐2 Variants of Concern
A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025
Dr. Nancy Jane Cox, PhD (1948–2026)
Epidemiology, Genomic Diversity, and Evolutionary Dynamics of Human Metapneumovirus Over 7 Years of Integrated Community‐ and Hospital‐Based Sentinel Surveillance in Senegal, 2018–2024
Country‐Level RSV‐Related Hospitalisation Rates Among Adults in High‐Income Countries From an Ensemble Model Based on Direct Viral Testing Incidence Data
Hemagglutination Inhibition and Alternate Serologic Responses Following Influenza A(H3N2) Virus Infection
Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia
Characteristics and Risk Factors Associated With Hospitalization and Severe Disease in Patients Aged ≥ 60 Years With Human Metapneumovirus Infection Over Three Consecutive Seasons (2021–2024) in Valladolid, Spain. The VALLAVIRUS Study
Incidence, Complications, and Quality of Life in Adults ≥ 60 Years Old With Laboratory‐Confirmed RSV Infections Attended in Primary Care and in Hospitals: A Study Over Three Seasons in Valladolid, Spain
Contribution of E190D and Q226H Mutations in HA to the Receptor‐Binding Profile of D1.1 Genotype H5N1 Viruses
Issue Information
Comparable Neutralizing Antibody Responses Following JN.1 and KP.2‐Based COVID‐19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity Study
Respiratory Syncytial Virus Transmission in Closed Community Settings That Include Children: A Systematic Review and Meta‐Analysis
Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024): Variant Turnover, Omicron Introductions, and Interregional Spread
EUVIMED